Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: satch88 who wrote (8103)	10/29/2009 10:24:40 PM
From: li3511	of 63326

> From an IMMU point of view, what results would we like to see Monday morning. Either... 1) A large progress payment from UCB to Immunomedics, or 2) Announcement of an expanded collaborative agreement between UCB and Immunomedics on a either a second product or second indication. Something along these lines would be nice: finance.yahoo.com With respect to HGS, I don't know. This isn't a zero sum game (they win, we lose), and out of respect to the patients one can only hope that the results are good. I still believe that they are the greatest placebo producers in the nation, and ultimately the clinical data on Benlysta will bear this out.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next